alexa Continuous Subcutaneous Insulin Infusion (CSII) Is Safe And Effective In The Management Of Children And Adolescents With Type 1 Diabetes: Report From A Specialized Center In Kuwait
ISSN: 2161-1017

Endocrinology & Metabolic Syndrome
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

6th International Conference on Diabetes and Endocrinology
December 05-07, 2016 Dallas, USA

Dina Omar
Dasman Diabetes Institute, Kuwait
ScientificTracks Abstracts: Endocrinol Metab Syndr
DOI: 10.4172/2161-1017.C1.017
Abstract
Aim: This study aims to assess the effectiveness and safety of CSII as an alternative to MDI in the management of children and adolescents with T1D in Dasman Diabetes Institute. Design: Retrospective prospective cohort study. Participants: Children and adolescents (<20 years old) with T1D who switched from MDI to CSII during 2011-2013. Data were collected from electronic health records. Effectiveness were measured by improvement in HbA1c and TDD, and safety by reduction in incidence of major complication (severe hypoglycemia (SH) and diabetic ketoacidosis (DKA)). Data were collected for 24 months prior to CSII use, and 30 months after. Results: The mean age of study cohort (n= 64) was 10.9 ± 4.8 years (mean ± SD). HbA1c dropped from 8.7±1.4% at baseline to 8.1±1.0% (0.6% absolute reduction) at 3 months (p<0.05). Sustainability of improvement was demonstrated only in those with high baseline HbA1c (>9.0%) with an absolute reduction of 2.4% from 10.6±1.3% to 8.8±2.2% at 30 months. There was no significant reduction in insulin requirement. Reduction in the incidence of SH was statistically significant while it was not significant for DKA. Conclusions: The use of CSII is effective in improving glycemic control of children and adolescents with T1D in the short term (3 months). Those who were in poor control (HbA1c >9.0%) at baseline, showed significant improvement of glycemic control, after 30 months. CSII use in our study cohort was safe as reduction in the incidence of acute major diabetic complications was demonstrated.
Biography

Dina Omar has graduated from Faulty of Medicine, Kuwait University in 2006 and joined the Internal Medicine Department in a government hospital in Kuwait. She got the membership of the Royal College of Physicians (London) in 2012, Post-graduate certificate of Fundamentals of Diabetes in 2015 from Joslin Diabetes Center in collaboration with Harvard Medical School (USA), and Master’s degree in Diabetes Care, Education and Management from University of Dundee in 2016. She is a Research Associate in Dasman Diabetes Center (Kuwait) and an Associate Faculty Staff Member in University of Dundee (Scotland).

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version